Immatics NV

NASDAQ:IMTX USA Biotechnology
Market Cap
$1.32 Billion
Market Cap Rank
#9055 Global
#4440 in USA
Share Price
$9.83
Change (1 day)
+0.20%
52-Week Range
$3.50 - $11.87
All Time High
$17.00
About

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as TCR-engineered autologous or allogeneic adoptive cell therapie… Read more

Immatics NV (IMTX) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: -0.119x

Based on the latest financial reports, Immatics NV (IMTX) has a cash flow conversion efficiency ratio of -0.119x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-57.64 Million) by net assets ($483.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Immatics NV - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Immatics NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Immatics NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Immatics NV ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Immatics NV (2018–2025)

The table below shows the annual cash flow conversion efficiency of Immatics NV from 2018 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $483.89 Million $-169.66 Million -0.351x -27.53%
2024-12-31 $574.84 Million $-158.03 Million -0.275x -439.47%
2023-12-31 $225.08 Million $18.23 Million 0.081x -82.76%
2022-12-31 $213.16 Million $100.13 Million 0.470x +113.82%
2021-12-31 $24.06 Million $-81.78 Million -3.399x -313.90%
2020-12-31 $104.26 Million $-85.61 Million -0.821x +52.75%
2019-12-31 $-40.84 Million $70.97 Million -1.738x +22.94%
2018-12-31 $-9.17 Million $20.68 Million -2.255x --